Related Experiment Video
Updated: Jun 26, 2026

An Open-Source Normothermic Perfusion System Designed for Research Scientists
Published on: July 18, 2025
A microbiological survey of bicarbonate-based replacement circuits in continuous veno-venous hemofiltration
Iain Moore1, Rammohan Bhat, Nicholas A Hoenich
1Department of Renal Medicine, Freeman Hospital, Newcastle-upon-Tyne, United Kingdom.
Objective:
The potential for clinically significant transfer of pyrogen-inducing material in dialysate and substitution fluids is well recognized in the setting of chronic hemodialysis and hemodiafiltration and has led to the establishment of strict standards for microbiological purity. Preliminary evidence has indicated the potential for fluid contamination in continuous renal replacement therapy, and although the scale of the problem in contemporary, industry-standard equipment is unclear. We aimed to define the microbial integrity of modern continuous veno-venous hemofiltration (CVVH) replacement fluid circuitry.
Design:
Twenty-four CVVH replacement fluid circuits (mean lifespan, 34.2 hours; range, 4-86) were studied at completion of therapy.
Setting:
The integrated critical care unit and cardiothoracic intensive care unit of the Freeman Hospital, Newcastle upon Tyne, United Kingdom, between January and August 2007.
Subjects:
Patients with renal failure receiving treatment with CVVH.
Interventions:
Nil.
Measurements:
Culture and endotoxin assays of replacement fluid, culture of endoluminal swabs, and electron microscopy of harvested tubing.
Main Results:
Of the 24 replacement fluid cultures, nine (mean lifespan 32.8 hours, range 5-79) breached European Pharmacopoeia standards for ultrapure water (<0.1 colony-forming units/mL). One of 24 endotoxin measurements breached European Pharmacopoeia standards (<0.03 endotoxin units/mL). Internal tubing cultures were negative, but electron microscopy revealed 13 of the 24 collected tubing samples to be contaminated with biofilm. Only seven of the 24 studied circuits proved to be free from microbial contamination.
Conclusions:
We have confirmed frequent breaches of microbial integrity in industry-standard, bicarbonate-based CVVH, indicating the potential for added risk to the vulnerable, critically ill patient. These findings are of particular concern given the need for systemic infusion of replacement fluid. Measures to reduce the levels of contamination and their impact are discussed.
Insights
Microbial contamination is common in continuous veno-venous hemofiltration (CVVH) replacement fluid circuits, posing risks to critically ill patients. This study highlights frequent breaches in microbial integrity in standard CVVH equipment.
Area of Science:
- Nephrology
- Critical Care Medicine
- Microbiology
Background:
- Clinically significant pyrogen transfer in dialysate and substitution fluids is a known risk in hemodialysis.
- Strict microbiological purity standards are established for chronic hemodialysis and hemodiafiltration.
- Preliminary evidence suggests fluid contamination potential in continuous renal replacement therapy (CRRT).
Purpose of the Study:
- To define the microbial integrity of modern continuous veno-venous hemofiltration (CVVH) replacement fluid circuitry.
- To assess the extent of microbial contamination in industry-standard CVVH equipment.
- To identify potential risks associated with fluid contamination in CRRT.
Main Methods:
- Studied 24 CVVH replacement fluid circuits at the completion of therapy.
- Conducted culture and endotoxin assays of replacement fluid.
- Performed endoluminal swab cultures and electron microscopy of tubing samples.
Main Results:
- Nine of 24 replacement fluid cultures exceeded European Pharmacopoeia standards for ultrapure water.
- One of 24 endotoxin measurements breached European Pharmacopoeia standards.
- Electron microscopy revealed biofilm contamination in 13 of 24 tubing samples; only 7 circuits were free from microbial contamination.
Conclusions:
- Frequent breaches of microbial integrity were confirmed in industry-standard, bicarbonate-based CVVH circuits.
- This contamination indicates a potential added risk to vulnerable, critically ill patients receiving systemic fluid infusion.
- Discusses measures to reduce contamination levels and their impact in CVVH therapy.
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Blood Studies I: ABG and VBG
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to reabsorb or...
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration